A high ranking FDA official resigned over the controversy of whether to allow the morning-after-pill (RU-486) as an over-the-counter drug. Susan Wood was the director of the FDA's Office of Womens Health. The FDA voted to postpone the vote indefinitely. Part of the controversy came when deciding that teenagers still needed a prescription for it and it coudnt determine how to enforce the age limit.
No comments:
Post a Comment